期刊文献+

不同检测系统总胆固醇测定结果的偏倚分析

Bias analysis on TCHOL results among different kinds of detection system
下载PDF
导出
摘要 目的:通过对不同检测系统进行方法对比分析,探讨各系统之间检测总胆固醇(TCHOL)结果是否具有可比性。方法:参照NCCLS《EP9-A文件》的要求,以可溯源的检测系统为目标检测系统,均采用酶法测定TCHOL对本院3个不同检测系统进行朗道质控物(水平2和水平3)各测定21次和测定新鲜血清标本40份。结果:朗道质控物和新鲜血清标本TCHOL测定经随机区组设计资料的方差分析,各检测系统间的差异均具有显著性(P<0.001)。各检测系统测定新鲜血清标本TCHOL可靠性系数α分别为0.9977、0.9990,各系统间的相关系数均大于0.975。各检测系统测定TCHOL的精密度CV均小于5%,以可溯源的检测系统1为目标检测系统,临床可接受性能评价TCHOL均超出临床接受范围。结论:3个不同检测系统测定TCHOL结果不具有可比性,当同一实验室同一检验项目存在两个或两个以上检测系统时,应进行结果的对比和偏倚评估。 Objective Discuss the comparability of total cholesterol(TCHOL) results among different detection system. Methods 3 different kinds of biochemistry detection systems were used to detect TCHOL concentration in 2 levels of Randox quality controls and 40 clinical sera according to EP9-A file. The collected data were dealt with statistics analysis. Results Analysis of variance showed TCHOL results from different control and patients scra have significant difference in different detection system (P 〈 0. 001 ). The correlation coefficient of each detection system were all above 0. 975 and the reliability coefficient of them was 0. 9977 and 0. 9990. Target system 1 was regarded as standard detection system and evaluated the acceptability of other detection system.. As a result, they were not accepted for TCHOL by clinic assessment. Conclusion The comparability of TCHOL results in 3 kinds of detection system did not accord to evaluation of clinical acceptability. If there are more than two systems for the same test, it is necessary to do method comparison and bias estimation in order to insure the comparability.
出处 《实用医学杂志》 CAS 2006年第1期88-90,共3页 The Journal of Practical Medicine
关键词 胆固醇 检测系统 偏倚 detection system Total Cholesterol Bias
  • 相关文献

参考文献5

  • 1JANSEN A C, AAKST-COHEN E S, TANCK M W, et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients [J]. J Intern Med, 2004, 256(6): 482 -490.
  • 2U.S. Department of Health and Human Services. Medicare,Medicaid and CLIA program: Regulations Implementing the Clinical Laboratory Improvement Amendment of 1988(CLIA) [J] . Finalrule. Fed Regist, 1992, 57 (40) : 7002 - 7186.
  • 3李健斋,王抒.浅议新修订的血脂水平划分方案[J].中华检验医学杂志,2001,24(5):261-262. 被引量:44
  • 4SIEKMANN L. Traceability of calibration for IVD industry: process for credentialing reference materials, reference methods and reference laboratories in europe [M] //Proceedings of the workshop on measurement traceability for clinical laboratory testing and in vitro diagnostic test systems. National Institute of Standards and Technology. Gaithershurg: MD, 2000:85 - 101.
  • 5魏吴 丛玉隆.医学实验室质量管理与认可指南[M].北京:中国计量出版社,2004.27-80.

二级参考文献2

  • 1中华心血管病杂志,1997年,25卷,169页
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部